CLINICAL AND LABORATORY OUTCOMES OF COMBINED L-ARGININE AND N-ACETYLCYSTEINE THERAPY FOR COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH A HISTORY OF ISCHEMIC STROKE
1 Termez Branch of Tashkent State Medical University, Termez, Surkhandarya Region, Republic of Uzbekistan
ReceivedAug 20, 2026
RevisedSep 04, 2026
PublishedSep 09, 2026
Annotatsiya
Background: Community-acquired pneumonia (CAP) may be clinically more severe in patients with previous ischemic stroke because neurological impairment, dysphagia, inflammation, and vascular dysfunction can interact to worsen respiratory recovery. Objective: This study evaluated clinical and laboratory outcomes associated with adjunctive L-arginine and N-acetylcysteine (NAC) in patients with CAP and a history of ischemic stroke. Methods: The study included 150 patients with CAP. Patients with previous ischemic stroke received standard therapy alone or standard therapy supplemented with L-arginine, NAC, or both agents. Outcomes included C-reactive protein (CRP), procalcitonin (PCT), vascular endothelial growth factor (VEGF), nitric oxide (NO), endothelin-1 (ET-1), National Institutes of Health Stroke Scale (NIHSS), CURB-65, and hospitalization duration. Results: At baseline, the post-stroke CAP group had higher CRP, PCT, VEGF, and ET-1 and lower NO than the non-stroke comparison group. The combined-treatment subgroup showed the largest reported changes: CRP decreased 79.5%, PCT 80.7%, VEGF 42.5%, and ET-1 46.0%, while NO increased 59.2%. Post-treatment NIHSS and CURB-65 scores were 5.8 and 1.0, and mean hospitalization was 10.4 days. Conclusion: Combined L-arginine and NAC was associated with the most favorable biomarker and clinical profile, warranting prospective controlled confirmation before causal efficacy is inferred.
1. Ahmad, M., Ayaz, Z., Sinha, T., Soe, T. M., Tutwala, N., Alrahahleh, A. A., Agbor, D. B. A., & Ali, N. (2024). Risk factors for the development of pneumonia in stroke patients: A systematic review and meta-analysis. Cureus, 16(3), e57077. https://doi.org/10.7759/cureus.57077
2. Bai, Y., Sun, L., Yang, T., Sun, K., Chen, J., & Hui, R. (2009). Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: A meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition, 89(1), 77–84. https://doi.org/10.3945/ajcn.2008.26544
3. Böger, R. H. (2007). The pharmacodynamics of L-arginine. The Journal of Nutrition, 137(6 Suppl 2), 1650S–1655S. https://doi.org/10.1093/jn/137.6.1650S
4. Böhm, F., & Pernow, J. (2007). The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovascular Research, 76(1), 8–18. https://doi.org/10.1016/j.cardiores.2007.06.004
5. Brott, T., Adams, H. P., Jr., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., Hertzberg, V., Rorick, M., Moomaw, C. J., & Walker, M. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864–870. https://doi.org/10.1161/01.STR.20.7.864
6. Chang, M. C., Choo, Y. J., Seo, K. C., & Yang, S. (2022). The relationship between dysphagia and pneumonia in acute stroke patients: A systematic review and meta-analysis. Frontiers in Neurology, 13, 834240. https://doi.org/10.3389/fneur.2022.834240
7. Kishore, A. K., Vail, A., Chamorro, A., Garau, J., Hopkins, S. J., Di Napoli, M., Kalra, L., Langhorne, P., Montaner, J., Roffe, C., Rudd, A. G., Tyrrell, P. J., van de Beek, D., Woodhead, M., Meisel, A., & Smith, C. J. (2015). How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis. Stroke, 46(5), 1202–1209. https://doi.org/10.1161/STROKEAHA.114.007843
8. Lim, W. S., van der Eerden, M. M., Laing, R., Boersma, W. G., Karalus, N., Town, G. I., Lewis, S. A., & Macfarlane, J. T. (2003). Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax, 58(5), 377–382. https://doi.org/10.1136/thorax.58.5.377
9. Liu, D., Su, L.-X., Guan, W., Xiao, K., & Xie, L.-X. (2016). Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis. Respirology, 21(2), 280–288. https://doi.org/10.1111/resp.12704
10. Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I., & Whitney, C. G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45–e67. https://doi.org/10.1164/rccm.201908-1581ST
11. Rodrigues-Krause, J., Krause, M., Rocha, I. M. G. da, Umpierre, D., & Fayh, A. P. T. (2019). Association of L-arginine supplementation with markers of endothelial function in patients with cardiovascular or metabolic disorders: A systematic review and meta-analysis. Nutrients, 11(1), 15. https://doi.org/10.3390/nu11010015
12. Rushworth, G. F., & Megson, I. L. (2014). Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits. Pharmacology & Therapeutics, 141(2), 150–159. https://doi.org/10.1016/j.pharmthera.2013.09.006
13. Smith, C. J., Kishore, A. K., Vail, A., Chamorro, A., Garau, J., Hopkins, S. J., Di Napoli, M., Kalra, L., Langhorne, P., Montaner, J., Roffe, C., Rudd, A. G., Tyrrell, P. J., van de Beek, D., Woodhead, M., & Meisel, A. (2015). Diagnosis of stroke-associated pneumonia: Recommendations from the Pneumonia in Stroke Consensus Group. Stroke, 46(8), 2335–2340. https://doi.org/10.1161/STROKEAHA.115.009617
14. Westendorp, W. F., Nederkoorn, P. J., Vermeij, J.-D., Dijkgraaf, M. G., & van de Beek, D. (2011). Post-stroke infection: A systematic review and meta-analysis. BMC Neurology, 11, 110. https://doi.org/10.1186/1471-2377-11-110
Maqolaga iqtibos keltirish andozasi
Rasulova Khurshidakhon (2026). CLINICAL AND LABORATORY OUTCOMES OF COMBINED L-ARGININE AND N-ACETYLCYSTEINE THERAPY FOR COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH A HISTORY OF ISCHEMIC STROKE. Science and Innovation, 5(8), 54-62. https://doi.org/10.67620/sai.58d0007